Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-25-000007
Filing Date
2025-01-03
Accepted
2025-01-03 19:20:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12165
2 EXHIBIT 24 ex_24.htm EX-24 4915
  Complete submission text file 0001019056-25-000007.txt   18773
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Subject) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92997 | Film No.: 25508587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912
Business Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912 864-990-3233
Long Focus Capital Management, LLC (Filed by) CIK: 0001602716 (see all company filings)

EIN.: 462772035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A